Bank of New York Mellon »

Intra Cellular Therapies shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2024-03-31 $26M 376k 69.20
2023-12-31 $30M 415k 71.62
2023-09-30 $21M 404k 52.09
2023-06-30 $25M 398k 63.32
2023-03-31 $21M 387k 54.15
2022-12-31 $21M 389k 52.92
2022-09-30 $18M 389k 46.00
2022-06-30 $22M 383k 57.08
2022-03-31 $24M 386k 61.19
2021-12-31 $19M 367k 52.35
2021-09-30 $13M 345k 37.28
2021-06-30 $14M 332k 40.82
2021-03-31 $10M 305k 33.93
2020-12-31 $9.3M 292k 31.80
2020-09-30 $8.0M 312k 25.66
2020-06-30 $6.4M 250k 25.68
2020-03-31 $3.6M 232k 15.37
2019-12-31 $6.5M 189k 34.31
2019-09-30 $1.4M 190k 7.47
2019-06-30 $2.7M 205k 12.98
2019-03-31 $2.6M 215k 12.18
2018-12-31 $2.4M 210k 11.39
2018-09-30 $4.5M 208k 21.70
2018-06-30 $3.7M 207k 17.67
2018-03-31 $4.4M 209k 21.05
2017-12-31 $3.1M 215k 14.48
2017-06-30 $2.1M 171k 12.41
2017-03-31 $2.4M 147k 16.25
2016-12-31 $2.2M 148k 15.09
2016-09-30 $2.4M 158k 15.23
2016-06-30 $6.9M 177k 38.83